Introduction
This statement is made pursuant to section 54 of the Modern Slavery Act 2015. It constitutes Genmed Enterprises Ltd (GEL) slavery and human trafficking statement for the financial year ended 07 April 2021. Of GEL’s wholly-owned subsidiaries, this statement covers the activities of Genmed Enterprises Ltd, which procure goods and services on its behalf.

Our Organisation
GEL is a medical device manufacturer with a global supply chain. We are focussed on improving patient outcome and providing effective solutions for our end users.
Our staff are directly employed and are not in any category which is generally seen to be vulnerable to modern slavery in this country, so our focus is to ensure there are policies and procedures in place for our contractors and suppliers.

Our Supply Chain
GEL is committed to continuously improving its practices to identify and eliminate any slavery and human trafficking in its business and supply chains, and to acting ethically and with integrity in all its business relationships. GEL uses a wide range of suppliers who supply goods for sale, provide services at events and support our
operations.

Policies
GEL has a number of policies, which aim to minimise the risk of modern slavery in our supply chain. These
include:

• Working with Suppliers and Partners Policy which sets out internal requirements for buying goods and services;
• Responsible Procurement Policy covering issues of human rights, child and forced labour and modern slavery, which GELs suppliers are required to comply with; and
• Whistleblowing Policy which encourages staff to report concerns including any related to modern slavery/trafficking and child or forced labour.

Due Diligence
We continue to monitor suppliers we believe present high modern slavery risks in our supply chain. This includes those who support the procurement of goods and materials.

All suppliers which we class as high risk must:
• Complete our Modern Slavery Act Due Diligence Questionnaire which covers their governance, policies, training and supply chain management processes; and
• On an annual basis and prior to sourcing, provide full detail of the supply chains they are proposing to commission goods from on behalf of GEL

A GEL team is responsible for assessing the information submitted by suppliers. Should a supplier fail to provide the information requested or to meet GEL expectations, GEL will take appropriate action, which may include not entering into a relationship or terminating the relationship with the supplier concerned.

Training
During the year, we have continued to provide advice and guidance to those teams who have direct responsibility for relevant supply chains and our Procurement team has participated in further modern slavery training. We also maintain a Modern Slavery Act Guidance document which is available to staff through Genmed Enterprises Ltd intranet.

Looking Ahead
Over the course of the next financial year we will continue to enhance our procedures to help us identify, prevent and mitigate any risks of modern slavery or human trafficking in relation to new and existing suppliers.

Approval
This statement has been formally approved by Genmed Enterprises Ltd and the Directors of Genmed Enterprises Limited.

Name: Meirion Thomas

Position: Director
Date: 07/08/2022